Literature DB >> 7783365

[The glutamic acid decarboxylase (GAD) antibodies and their clinical significance].

K Ogata1, K Ohta, H Kubo, A Yamaguchi, H Watanabe.   

Abstract

Since it was reported that the 64kD antigen that had been found to be the target of autoantibodies in the sera from IDDM patients was the same as GAD, GAD antibodies have been one of the focuses of many investigations. In this study, we developed a sensitive radioimmunoassay (RIA) system for GAD antibodies in human sera using native GAD purified from the pig brain. To confirm the relevance of pig GAD as the target antigen, we compared the sequences and antigenic activities among pig, rat and recombinant human GAD65. Based on the data from our and other laboratories, the homology of amino acid sequences between pig and human GAD65 was 96.4%. The coefficient of correlation between the results of human and pig GAD RIA was 0.948. The GAD antibody study group confirmed the clinical usefulness of GAD antibodies not only for the diagnosis of IDDM but also slowly progressive IDDM.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7783365

Source DB:  PubMed          Journal:  Rinsho Byori        ISSN: 0047-1860


  1 in total

1.  Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients.

Authors:  J Endl; H Otto; G Jung; B Dreisbusch; F Donie; P Stahl; R Elbracht; G Schmitz; E Meinl; M Hummel; A G Ziegler; R Wank; D J Schendel
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.